Connect with us
Lamictal
Company
Indications
- Approved
- adjunctive treatment of partial seizures in adults; adjunctive treatment of Lennox-Gastaut syndrome in pediatric and adult patients
- conversion to monotherapy in adults with partial seizures who are receiving treatment with a single enzyme-inducing anti-epileptic drug (EIAED)
- maintenance treatment of Bipolar I Disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy
- treatment of primary generalized tonic clonic seizures in adults and pediatric patients (2 years of age or older)